Back to top

Evaluation of implementation of technologies to assess, monitor and treat neurodevelopmental disorders

An evaluation of factors that influence the implementation of technologies to assess, monitor and treat neurodevelopmental disorders: a narrative systematic review

What we are doing:

The aim of this review is to identify the current evidence for technologies used clinically in the diagnosis, management, and treatment of neurodevelopmental disorders. Using pre-specified search terms, we will systematically search databases. Two reviewers will independently screen titles and abstracts for relevance. The full text of included articles will be judged against predetermined inclusion criteria. The technologies will be summarised on their evidence for: effectiveness (clinical/service), economic and user impact (acceptability/feasibility), and assessed for the quality of evidence and suitability for clinic adoption. The review will produce a template summarising the evidence and the findings will also be published. 

Why we are doing it:

Neurodevelopmental disorders represent a significant expenditure to the NHS. There are a lack of services offered for children, young people and adults suffering from these disorders. This means patients often do not have access to the best care, or have to wait a long time to receive an appropriate diagnosis and access available treatment options. There is a local need to be able to identify appropriate technologies to improve access to treatments and interventions within this population. An important starting point in this process is to summarise the evidence on the available technologies and evaluate their suitability for clinical adoption. 

What the benefits will be:

By creating a template that summarises and evaluates the existing evidence for technologies used to assess, monitor and treat neurodevelopmental disorders we shall: 

  1. Inform local commissioners on which technologies may be most suitable for clinical adoption 
  2. Inform the National Institute for Health and Care Excellence(NICE) on which technologies may be particularly suitable for review through the‘Health Apps Briefings’
  3. Provide an evidence base for the technologies which may not be selected by NICE for review but are of interest for commissioners and healthcare professionals

Who we are working with:

Study Team

  • Dr Charlotte Hall (Senior Research Fellow)
  • Dr Althea Valentine (Research Fellow)
  • Professor Chris Hollis (Professor of Child and Adolescent Psychiatry)
  • Dr Maddie Groom (Assistant Professor in Applied Psychology and Psychiatry)
  • Ms Nikki Brown (Patient and Public Involvement Lead)
  • Dr Jen Martin (Programme Manager MedTech Co-operative)
  • Dr Bethan Davies (Research Fellow)
  • Dr Emma Rowley (Senior Research Fellow)
  • Mr Joe Kilgariff (Advanced Nurse)
  • Mrs Emma Young (Information Specialist)

Steering group

  • Professor Richard Morriss (Professor of Psychiatry and Community Mental Health)
  • Dr Julie Clarke (Consultant Paediatrician, Lincolnshire)
  • Dr Neeta Kulkani (Consultant Paediatrician, Leicestershire)
  • Katharine Browne (Nottinghamshire CCG)
  • Georgie Hill (North Derbyshire CCG)
  • Dave Clarke (Service Provider, Leicestershire)
  • Elaine Egan-Morriss (Leicestershire CCG)
  • QbTech (Managing Director, Tony Doyle) 

Study Lead:

Name: Dr Althea Valentine and Dr Charlotte Hall

Role: Research Fellow and Senior Research Fellow

Organisation: University of Nottingham